Universal Registration Document 2022

Abivax’s Universal Registration Document 2022 “Document d’Enregistrement Universel” is available as PDF version in English and in French as well as in xHTML format (French version only).

Share Profile

Abivax SA has been listed on the Paris Stock Exchange since 26 June 2015.

  • ISIN code: FR0012333284
  • Symbol: ABVX
  • ICB Classification: Healthcare 4000/ Biotechnology 4573
  • Market: Euronext Paris-Compartment B
  • Type of Listing: continuous
  • Number of shares: 16,764,051 as of February 2022
  • Indices: CAC ALL SHARES, CAC All-Tradable, CAC MID&SMALL, CAC SMALL, CAC Health Care, CAC Pharma & Bio, and Next Biotech
  • Eligible to French PEA PME


LifeSci Capital | Alpha Series:

Adam Evertts


Sebastiaan van der Schoot

goetzpartners securities:

Chris Redhead

Degroof Petercam:

Christophe Dombu Youta

Bryan, Garnier & Co:

Dylan Van Haaften

Oddo BHF:

Martial Descoutures

Kepler Cheuvreux:

Damien Choplain


Mohamed Kaabouni

Investor Contact

Ligia Vela-Reid LifeSci Advisors lvela-reid@lifesciadvisors.com +44 (0) 7413 825310